Company to advance care through broader access to breadth of skin substitutes across four unique technology platforms Tissue Technologies Integra dermal regenerative templates, decellularized dermal scaffolds and amniotic tissue membranes are included in the ruling. PRINCETON, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, commends the Centers for Medicare & Medicaid Services (CMS) on its Calendar Year 2026 M ...